Jump to content

Drilldown: Medicines

Pharmacopedia
BrowseCategoriesLog in

Choose a table:


Medicines > classes : Empathogen or Psychostimulant & fda max: None

Use the filters below to narrow your results.

generic:
4-FA (1) · 5-APB (1) · 5-MAPB (1) · 6-APB (1) · 6-APDB (1) · Butylone (1) · Dexmethylphenidate (1) · Dextroamphetamine (1) · Ephylone (1) · Ethylone (1) · Fenethylline (1) · MDA (1) · MDAI (1) · MDEA (1) · MDMA (1) · Mephedrone (1) · Methylone (1) · Methylphenidate (1) · PMA (1) · PMMA (1)
brand:
None (16) · Captagon (1) · Dexedrine (1) · Focalin, Focalin XR (1) · Ritalin, Ritalin LA, Concerta, Metadate CD, Daytrana, Quillivant XR (1)
classes: (Click arrow to add another value)
mechanism:
MAO inhibitor; monoamine releasing agent (1) · MAO inhibitor; serotonin releasing agent (1) · Monoamine releasing agent (4) · Monoamine releasing agent; 5-HT2A agonist (1) · Monoamine releasing agent; serotonergic at higher doses (1) · Norepinephrine–dopamine reuptake inhibition (DAT, NET) (1) · Norepinephrine–dopamine reuptake inhibition (DAT, NET), d-threo enantiomer of methylphenidate (1) · Prodrug of amphetamine + theophylline (1) · Serotonin releasing agent (2) · Serotonin releasing agent; 5-HT2A agonist (3) · Serotonin/dopamine/norepinephrine releasing agent; 5-HT2A agonist (1) · Serotonin/norepinephrine/dopamine releasing agent (3)
uses:
None (18) · ADHD, narcolepsy (1) · '"`UNIQ--vote-00000150-QINU`"', '"`UNIQ--vote-00000151-QINU`"' (1)
starting dose:
None (20)
preparations:
None (20)
fda max: (Click arrow to add another value)
routes:
None (18) · Oral (2) · transdermal (1)
onset:
None (18) · 20–60 min (oral) (1) · 30–60 min (1)
duration:
None (18) · IR 3–5 h; LA/SR 6–8 h; Concerta 10–12 h; Daytrana ~9 h wear time (1) · IR 4–6 h; XR 8–12 h (1)
halflife:
None (18) · 2.2 h (IR parent); ~3 h (XR parent) (1) · 2–3 h (parent compound) (1)
bioavailability:
None (18) · ~22–25% (1) · ~30% (high first-pass) (1)
pregnancy:
None (18) · Category C (1) · Pregnancy categories were retired by FDA in 2015. Limited reproductive data with small observational signal for cardiac malformations; risk-benefit decision, with many patients deferring ADHD treatment during pregnancy. See pregnancy_details for the full discussion. (1)
legal:
None (18) · Schedule II (2)

Showing below up to 20 results in range #1 to #20.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"